Background: Pulmonary infections including pneumonia during sickle cell disease are common and fall within the definition of acute chest syndrome. This clinical syndrome is defined by the association of a recent thoracic radiological abnormality with a clinical manifestation: chest pain, fever, or dyspnea. Methods: This is an observational, descriptive study of a special case discovered during a pediatric consultation at the university clinics of Kinshasa. Its presentation being a case not yet found at the university clinics makes its publication valuable. Result: We report the observation of an 8-year-old patient with hand-foot-mouth syndrome and 2 previous pneumonias, without any notion of parental consanguinity. On his physical examination, he presented crackling rales at the base of the right lung, O2 desaturation at 88% in open air. The emergency assessment revealed a hemoglobin level of 8 g/dl, a leukocytosis of 18,000/mm3, a leukocyte formula: N83%L12% M5%E0%B0%; C Reactive Protein at 48 mg/l. The thick film was negative. The chest X-ray (Front) revealed right basal lung disease of presumably infectious origin. Conclusion: This work emphasizes the frequency of the occurrence of pneumonia and its potential seriousness in a little-known sickle cell patient.
Cite this paper
Ngonde, F. N. , Nkodila, A. N. , Bifu, C. , Kumbu, J. M. , Sekele, P. M. N. and Aketi, L. P. (2024). Pneumonia as a Sign of Sickle Cell Disease: About a Case with Review of the Literature. Open Access Library Journal, 11, e1637. doi: http://dx.doi.org/10.4236/oalib.1111637.
Pereira-Martins, D.A., Domingos, I.F., Belini-Junior, E., Coelho-Silva, J.L., Weinhäuser, I., Araújo, A.S., et al. (2021) Association of HMIP1 C-893A Polymorphism and Disease Severity in Patients with Sickle Cell Anemia. Hematology, Transfusion and Cell Therapy, 43, 243-248.
https://doi.org/10.1016/j.htct.2020.03.006
Wastnedge, E., Waters, D., Patel, S., Morrison, K., Goh, M.Y., Adeloye, D., et al. (2018) The Global Burden of Sickle Cell Disease in Children under Five Years of Age: A Systematic Review and Meta-Analysis. Journal of Global Health, 8, Article 021103. https://doi.org/10.7189/jogh.08.021103
Nardo-Marino, A., Brousse, V. and Rees, D. (2020) Emerging Therapies in Sickle Cell Disease. British Journal of Haematology, 190, 149-172. https://doi.org/10.1111/bjh.16504
Frangoul, H., Altshuler, D., Cappellini, M.D., Chen, Y., Domm, J., Eustace, B.K., et al. (2021) Crispr-Cas9 Gene Editing for Sickle Cell Disease and Β-Thalassemia. New England Journal of Medicine, 384, 252-260. https://doi.org/10.1056/nejmoa2031054
Salim, A.S., Mwita, E., Antwi, J.S., Agunkejoye, O. and Mdliva, P. (2021) Living with Sickle Cell Disease: Voices from Sub-Saharan Africa. The Lancet Haematology, 8, e684-e685. https://doi.org/10.1016/s2352-3026(21)00276-3
Esoh, K., Wonkam-Tingang, E. and Wonkam, A. (2021) Sickle Cell Disease in Sub-Saharan Africa: Transferable Strategies for Prevention and Care. The Lancet Haematology, 8, e744-e755. https://doi.org/10.1016/s2352-3026(21)00191-5
Zhou, A.E. and Travassos, M.A. (2022) Bringing Sickle-Cell Treatments to Children in Sub-Saharan Africa. New England Journal of Medicine, 387, 488-491. https://doi.org/10.1056/nejmp2201763
Mattioni, S., Stojanovic, K.S., Girot, R. and Lionnet, F. (2016) La drépanocytose en France. Revue Francophone des Laboratoires, 2016, 61-66. https://doi.org/10.1016/s1773-035x(16)30129-0
Mukinayi, B.M., Cibeyibeyi, G.K., Tumba, G.D. and Gulbis, B. (2021) Drépanocytose en République Démocratique du Congo: Quels sont les obstacles à un traitement par hydroxyurée? Pan African Medical Journal, 38, Article 41. https://doi.org/10.11604/pamj.2021.38.41.18718
Legrand, A., Bignon, A., Borel, M., Zerbib, P., Langlois, J., et al. (2005) Prévention du risque infectieux postopératoire chez les patients splénectomisés. Annales Françaises d’Anesthésie et de Réanimation, 24, 807-813. https://doi.org/10.1016/j.annfar.2005.05.002
Vichinsky, E.P., Neumayr, L.D., Earles, A.N., Williams, R., Lennette, E.T., Dean, D., et al. (2000) Causes and Outcomes of the Acute Chest Syndrome in Sickle Cell Disease. New England Journal of Medicine, 342, 1855-1865. https://doi.org/10.1056/nejm200006223422502
Knight-Madden, J.A. and Hambleton, I.R. (2003) Inhaled Bronchodilators for Acute Chest Syndrome in People with Sickle Cell Disease. Cochrane Database of Systematic Reviews, No. 9, CD003733.